The Added Value of [18F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report
Authors:
- Antonio PirasAPAntonio Piras
- Riccardo LaudicellaRiccardo Laudicella
- Luca BoldriniLuca Boldrini
- Andrea D’avieroADAndrea D’aviero
- Antonella SanfratelloASAntonella Sanfratello
- Antonino La RoccaARAntonino La Rocca
- Salvatore ScurriaSSSalvatore Scurria
- Giuseppe SalamoneGSGiuseppe Salamone
- Pierpaolo AlongiPAPierpaolo Alongi
- Tommaso AngileriTATommaso Angileri
- Antonino DaidoneADAntonino Daidone
Open Access
Abstract
In the management of prostate cancer (PCa), correct staging is crucial in order to assess the right therapeutic approach. [18F]Choline PET/CT has been shown to provide more accurate staging information than conventional imaging approaches. The aim of this paper is to provide a real practice demonstration of the impact of [18F]Choline PET/CT on low-risk prostate cancer staging and clinical management. We report a 64-year-old man with biochemical PCa recurrence diagnosis after transurethral resection of the prostate. The patient, after the detection of an increased level of PSA, underwent multi-parametric prostate magnetic resonance imaging (mpMRI) that did not show evidence of disease. The patient was admitted to perform [18F]Choline PET/CT that showed a macroscopic prostate recurrence. Patient underwent photon external beam radiation therapy (EBRT) treatment, and [18F]Choline PET/CT was also used to define treatment volumes. At 3- and 6-month clinical follow-up evaluations, no late toxicity was detected and a significant reduction in PSA value was shown. Therefore, our case highlights the potential usefulness of [18F]Choline PET/CT for the staging of low-risk prostate cancer and its impact on the management and quality of life of such patients. The presented case should urge the scientific community to enhance larger and multicentric studies, assessing more extensively the potential impact of [18F]Choline PET/CT in this clinical scenario.Keywords
This publication has 29 references indexed in Scilit:
- Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision MakingRadiologic Clinics of North America, 2018
- Linee guida Carcinoma della Prostata - AIRO, 2016Tumori Journal, 2016
- Utility of PET for Radiotherapy Treatment PlanningPET Clinics, 2015
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted TherapyJournal of Nuclear Medicine, 2015
- Meta-analysis of 11C-choline and 18F-choline PET/CT for management of patients with prostate cancerNuclear Medicine Communications, 2014
- The role of magnetic resonance imaging in the diagnosis and management of prostate cancerBJU International, 2013
- Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysisEuropean Urology, 2013
- Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate CancerUrology, 2009
- Kinetics of [ 11 C]choline uptake in prostate cancer: a PET stydyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Rectal Examination in Volume Determination of Carcinoma of the Prostate: Clinical and Anatomical CorrelationsJournal of Urology, 1986